This brand name is authorized in Japan
The drug PHENOBAL contains one active pharmaceutical ingredient (API):
|
1
Phenobarbital
UNII YQE403BP4D - PHENOBARBITAL
|
|
Phenobarbital has sedative effects and has some protective action against all varieties of human partial and generalised epilepsy, with the exception of absence seizures. Phenobarbital is also effective in preventing seizures in the corresponding experimental animal models of epilepsy. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N03AA02 | Phenobarbital | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AA Barbiturates and derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1125003B2031, 1125003X1156, 1125004F1023, 1125004S1030, 1125402A1054 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
